DIN 02170698 — PMS-METHOTREXATE 2.5 MG
PMS-METHOTREXATE is a tablet of Methotrexate marketed by PHARMASCIENCE INC. The full Methotrexate monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.
- DIN
- 02170698
- Brand name
- PMS-METHOTREXATE
- Active ingredient
- Methotrexate
- Strength
- 2.5 MG
- Dosage form
- TABLET
- Route
- ORAL
- Manufacturer
- PHARMASCIENCE INC
- Health Canada status
- MARKETED
- Drug class
- Antimetabolite / folate antagonist (antineoplastic agent and disease-modifying antirheumatic drug)
Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.
Other Methotrexate products
| DIN | Brand | Strength | Form | Manufacturer | Status |
|---|---|---|---|---|---|
| 02509067 | ACH-METHOTREXATE | 2.5 MG | TABLET | ACCORD HEALTHCARE INC | MARKETED |
| 02182963 | APO-METHOTREXATE | 2.5 MG | TABLET | APOTEX INC | MARKETED |
| 02524023 | AURO-METHOTREXATE | 2.5 MG | TABLET | AURO PHARMA INC | MARKETED |
| 02553740 | JAMP METHOTREXATE TABLETS | 10 MG | TABLET | JAMP PHARMA CORPORATION | MARKETED |
| 02534916 | M-METHOTREXATE | 2.5 MG | TABLET | MANTRA PHARMA INC | MARKETED |
| 02530775 | METHOFILL SELF-DOSE INJECTOR | 10 MG | SOLUTION | ACCORD HEALTHCARE INC | MARKETED |
| 02530783 | METHOFILL SELF-DOSE INJECTOR | 12.5 MG | SOLUTION | ACCORD HEALTHCARE INC | MARKETED |
| 02530791 | METHOFILL SELF-DOSE INJECTOR | 15 MG | SOLUTION | ACCORD HEALTHCARE INC | MARKETED |
| 02530805 | METHOFILL SELF-DOSE INJECTOR | 17.5 MG | SOLUTION | ACCORD HEALTHCARE INC | MARKETED |
| 02530813 | METHOFILL SELF-DOSE INJECTOR | 20 MG | SOLUTION | ACCORD HEALTHCARE INC | MARKETED |
| 02530848 | METHOFILL SELF-DOSE INJECTOR | 22.5 MG | SOLUTION | ACCORD HEALTHCARE INC | MARKETED |
| 02530856 | METHOFILL SELF-DOSE INJECTOR | 25 MG | SOLUTION | ACCORD HEALTHCARE INC | MARKETED |
| 02327236 | METHOTREXATE INJECTION BP | 25 MG | SOLUTION | ACCORD HEALTHCARE INC | MARKETED |
| 02464365 | METHOTREXATE INJECTION BP | 25 MG | SOLUTION | ACCORD HEALTHCARE INC | MARKETED |
| 02474735 | METHOTREXATE INJECTION BP | 25 MG | SOLUTION | ACCORD HEALTHCARE INC | MARKETED |
| 02474891 | METHOTREXATE INJECTION BP | 25 MG | SOLUTION | ACCORD HEALTHCARE INC | MARKETED |
| 02182947 | METHOTREXATE INJECTION USP | 10 MG | SOLUTION | PFIZER CANADA ULC | MARKETED |
| 02182777 | METHOTREXATE INJECTION USP | 25 MG | SOLUTION | PFIZER CANADA ULC | MARKETED |
| 02182955 | METHOTREXATE INJECTION USP | 25 MG | SOLUTION | PFIZER CANADA ULC | MARKETED |
| 02182971 | METHOTREXATE INJECTION USP | 25 MG | SOLUTION | PFIZER CANADA ULC | MARKETED |
| 02422174 | METHOTREXATE INJECTION, BP | 10 MG | SOLUTION | PHARMASCIENCE INC | MARKETED |
| 02422182 | METHOTREXATE INJECTION, BP | 15 MG | SOLUTION | PHARMASCIENCE INC | MARKETED |
| 02422190 | METHOTREXATE INJECTION, BP | 20 MG | SOLUTION | PHARMASCIENCE INC | MARKETED |
| 02422204 | METHOTREXATE INJECTION, BP | 25 MG | SOLUTION | PHARMASCIENCE INC | MARKETED |
| 02422166 | METHOTREXATE INJECTION, BP | 7.5 MG | SOLUTION | PHARMASCIENCE INC | MARKETED |
| 02417626 | METHOTREXATE INJECTION, USP | 25 MG | SOLUTION | STRIDES PHARMA CANADA INC | DORMANT |
| 02099705 | METHOTREXATE SODIUM INJECTION | 25 MG | SOLUTION | TEVA CANADA LIMITED | MARKETED |
| 02491281 | METHOTREXATE SUBCUTANEOUS | 10 MG | SOLUTION | ACCORD HEALTHCARE INC | MARKETED |
| 02491303 | METHOTREXATE SUBCUTANEOUS | 12.5 MG | SOLUTION | ACCORD HEALTHCARE INC | MARKETED |
| 02491311 | METHOTREXATE SUBCUTANEOUS | 15 MG | SOLUTION | ACCORD HEALTHCARE INC | MARKETED |
| 02491338 | METHOTREXATE SUBCUTANEOUS | 17.5 MG | SOLUTION | ACCORD HEALTHCARE INC | MARKETED |
| 02491346 | METHOTREXATE SUBCUTANEOUS | 20 MG | SOLUTION | ACCORD HEALTHCARE INC | MARKETED |
| 02491354 | METHOTREXATE SUBCUTANEOUS | 22.5 MG | SOLUTION | ACCORD HEALTHCARE INC | MARKETED |
| 02491362 | METHOTREXATE SUBCUTANEOUS | 25 MG | SOLUTION | ACCORD HEALTHCARE INC | MARKETED |
| 02182750 | METHOTREXATE TABLETS, USP | 10 MG | TABLET | PFIZER CANADA ULC | MARKETED |
| 02454831 | METOJECT SUBCUTANEOUS | 10 MG | SOLUTION | MEDEXUS PHARMACEUTICALS INC. | MARKETED |
| 02454750 | METOJECT SUBCUTANEOUS | 12.5 MG | SOLUTION | MEDEXUS PHARMACEUTICALS INC. | MARKETED |
| 02454858 | METOJECT SUBCUTANEOUS | 15 MG | SOLUTION | MEDEXUS PHARMACEUTICALS INC. | MARKETED |
| 02454769 | METOJECT SUBCUTANEOUS | 17.5 MG | SOLUTION | MEDEXUS PHARMACEUTICALS INC. | MARKETED |
| 02454866 | METOJECT SUBCUTANEOUS | 20 MG | SOLUTION | MEDEXUS PHARMACEUTICALS INC. | MARKETED |
| 02454777 | METOJECT SUBCUTANEOUS | 22.5 MG | SOLUTION | MEDEXUS PHARMACEUTICALS INC. | MARKETED |
| 02454874 | METOJECT SUBCUTANEOUS | 25 MG | SOLUTION | MEDEXUS PHARMACEUTICALS INC. | MARKETED |
| 02539608 | PMS-METHOTREXATE INJECTION | 10 MG | SOLUTION | PHARMASCIENCE INC | MARKETED |
| 02539616 | PMS-METHOTREXATE INJECTION | 12.5 MG | SOLUTION | PHARMASCIENCE INC | MARKETED |
| 02539624 | PMS-METHOTREXATE INJECTION | 15 MG | SOLUTION | PHARMASCIENCE INC | MARKETED |
| 02539632 | PMS-METHOTREXATE INJECTION | 17.5 MG | SOLUTION | PHARMASCIENCE INC | MARKETED |
| 02539640 | PMS-METHOTREXATE INJECTION | 20 MG | SOLUTION | PHARMASCIENCE INC | MARKETED |
| 02539659 | PMS-METHOTREXATE INJECTION | 22.5 MG | SOLUTION | PHARMASCIENCE INC | MARKETED |
| 02539667 | PMS-METHOTREXATE INJECTION | 25 MG | SOLUTION | PHARMASCIENCE INC | MARKETED |
| 02561956 | PMS-METHOTREXATE TABLETS | 10 MG | TABLET | PHARMASCIENCE INC | MARKETED |